These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27725631)

  • 1. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers.
    Allaoui R; Bergenfelz C; Mohlin S; Hagerling C; Salari K; Werb Z; Anderson RL; Ethier SP; Jirström K; Påhlman S; Bexell D; Tahin B; Johansson ME; Larsson C; Leandersson K
    Nat Commun; 2016 Oct; 7():13050. PubMed ID: 27725631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
    Broad RV; Jones SJ; Teske MC; Wastall LM; Hanby AM; Thorne JL; Hughes TA
    Br J Cancer; 2021 Mar; 124(6):1110-1120. PubMed ID: 33398063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
    Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
    Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.
    Guillén Díaz-Maroto N; Sanz-Pamplona R; Berdiel-Acer M; Cimas FJ; García E; Gonçalves-Ribeiro S; Albert N; Garcia-Vicién G; Capella G; Moreno V; Salazar R; Villanueva A; Molleví DG
    Clin Cancer Res; 2019 Jul; 25(14):4466-4479. PubMed ID: 30979739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
    Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
    J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer.
    Jung YY; Lee YK; Koo JS
    Tumour Biol; 2015 Nov; 36(11):8685-95. PubMed ID: 26044562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal integrin α11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors.
    Smeland HY; Lu N; Karlsen TV; Salvesen G; Reed RK; Stuhr L
    BMC Cancer; 2019 Mar; 19(1):234. PubMed ID: 30876468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.
    Prasmickaite L; Tenstad EM; Pettersen S; Jabeen S; Egeland EV; Nord S; Pandya A; Haugen MH; Kristensen VN; Børresen-Dale AL; ; Engebråten O; Maelandsmo GM
    Mol Oncol; 2018 Sep; 12(9):1540-1558. PubMed ID: 29741811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.
    Ananthula S; Sinha A; El Gassim M; Batth S; Marshall GD; Gardner LH; Shimizu Y; ElShamy WM
    Oncotarget; 2016 Apr; 7(15):20869-89. PubMed ID: 26989079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
    Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
    Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
    [No Abstract]   [Full Text] [Related]  

  • 12. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
    Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
    Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer.
    Hollmén M; Roudnicky F; Karaman S; Detmar M
    Sci Rep; 2015 Mar; 5():9188. PubMed ID: 25776849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
    Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
    J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Na⁺/H⁺ exchanger (NHE1) as a novel co-adjuvant target in paclitaxel therapy of triple-negative breast cancer cells.
    Amith SR; Wilkinson JM; Baksh S; Fliegel L
    Oncotarget; 2015 Jan; 6(2):1262-75. PubMed ID: 25514463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.
    Jung HY; Lee DK; Lee M; Choi SH; Park JD; Ko ES; Lee J; Park KS; Jung HY
    Oncoimmunology; 2023; 12(1):2190671. PubMed ID: 36950218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
    Funakoshi Y; Wang Y; Semba T; Masuda H; Hout D; Ueno NT; Wang X
    PLoS One; 2019; 14(9):e0222336. PubMed ID: 31532791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
    Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
    Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.